Novavax (NVAX) stock forecast for 2022. Forecast tables and graphs.

Novavax (NVAX) stock forecast for 2022

The forecast has been updated: October 28, 2021 12:21


Novavax stock price online today

Analyst Target Price

264.2

Dividend Date

10.05.2019

Ex Dividend Date

-

Last Split Factor

1:20

Last Split Date

10.05.2019

Should you buy or sell Novavax stock stock today? What is the projected target price level for 2022? How much will it cost in 2022? Novavax stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2022.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $264.2 target price for Novavax stock stock.

Today 200 Day Moving Average is the resistance level (197.37 $).

50 Day Moving Average is the resistance level (197.51 $).




NVAX Forecast for 2022

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 107.64 96.98 127.98 24.22 %
Feb 116.03 101.07 135.53 25.43 %
Mar 110.12 100.21 130.93 23.46 %
Apr 130.93 99.90 143.10 30.19 %
May 158.03 145.23 176.52 17.73 %
Jun 144.75 123.48 176.89 30.20 %
Jul 130.86 117.51 150.88 22.12 %
Aug 127.33 109.37 141.84 22.89 %
Sep 136.49 121.34 152.05 20.20 %
Oct 153.69 126.95 175.36 27.61 %
Nov 138.94 130.18 171.86 24.25 %
Dec 168.53 140.22 190.78 26.50 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Novavax stock.


Novavax overview

Novavax Address

20 FIRSTFIELD ROAD, GAITHERSBURG, MD, US

Market Capitalization

10 751 142 000 $

EBITDA

-157 414 000

PE Ratio

None

PEG Ratio

0

Dividend Per Share

None

Dividend Yield

0

EPS

-13.84

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

7.39

Trailing PE

0

Forward PE

2.904

EV To Revenue

7.09

EV To EBITDA

0

52 Week High

331.68

52 Week Low

76.59

50 Day Moving Average

197.51

200 Day Moving Average

197.37

Shares Outstanding

74484000

Shares Float

74091000

Shares Short Prior Month

6074100

Short Ratio

1.47

Percent Insiders

0.567

Percent Institutions

54.43

Novavax stock forecast for this year


Novavax stock forecast for Jan 2022.
Estimated Average Forecasted Novavax Price: 107.64. Negative monthly dynamics of the instrument is expected with 24.222% volatility is expected.

Pessimistic forecast: 96.98

Optimistic: 127.98


Novavax stock forecast for Feb 2022.
Estimated Average Forecasted Novavax Price: 116.03. Positive monthly dynamics of the instrument is expected with 25.428% volatility is expected.

Pessimistic forecast: 101.07

Optimistic: 135.53


Novavax stock forecast for Mar 2022.
Estimated Average Forecasted Novavax Price: 110.12. Negative monthly dynamics of the instrument is expected with 23.465% volatility is expected.

Pessimistic forecast: 100.21

Optimistic: 130.93


Novavax stock forecast for Apr 2022.
Estimated Average Forecasted Novavax Price: 130.93. Positive monthly dynamics of the instrument is expected with 30.192% volatility is expected.

Pessimistic forecast: 99.90

Optimistic: 143.10


Novavax stock forecast for May 2022.
Estimated Average Forecasted Novavax Price: 158.03. Positive monthly dynamics of the instrument is expected with 17.726% volatility is expected.

Pessimistic forecast: 145.23

Optimistic: 176.52


Novavax stock forecast for Jun 2022.
Estimated Average Forecasted Novavax Price: 144.75. Negative monthly dynamics of the instrument is expected with 30.197% volatility is expected.

Pessimistic forecast: 123.48

Optimistic: 176.89


Novavax stock forecast for Jul 2022.
Estimated Average Forecasted Novavax Price: 130.86. Negative monthly dynamics of the instrument is expected with 22.116% volatility is expected.

Pessimistic forecast: 117.51

Optimistic: 150.88


Novavax stock forecast for Aug 2022.
Estimated Average Forecasted Novavax Price: 127.33. Negative monthly dynamics of the instrument is expected with 22.891% volatility is expected.

Pessimistic forecast: 109.37

Optimistic: 141.84


Novavax stock forecast for Sep 2022.
Estimated Average Forecasted Novavax Price: 136.49. Positive monthly dynamics of the instrument is expected with 20.197% volatility is expected.

Pessimistic forecast: 121.34

Optimistic: 152.05


Novavax stock forecast for Oct 2022.
Estimated Average Forecasted Novavax Price: 153.69. Positive monthly dynamics of the instrument is expected with 27.607% volatility is expected.

Pessimistic forecast: 126.95

Optimistic: 175.36


Novavax stock forecast for Nov 2022.
Estimated Average Forecasted Novavax Price: 138.94. Negative monthly dynamics of the instrument is expected with 24.252% volatility is expected.

Pessimistic forecast: 130.18

Optimistic: 171.86


Novavax stock forecast for Dec 2022.
Estimated Average Forecasted Novavax Price: 168.53. Positive monthly dynamics of the instrument is expected with 26.502% volatility is expected.

Pessimistic forecast: 140.22

Optimistic: 190.78



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 127.71 (27.10.2021) -0.33 %
AbbVie Inc.
ABBV 108.4 (27.10.2021) -1.00 %
Aeterna Zentaris Inc.
AEZS 0.5889 (27.10.2021) -4.06 %
Allakos Inc.
ALLK 106.71 (27.10.2021) -4.63 %
Allogene Therapeutics, Inc.
ALLO 15.94 (27.10.2021) -0.50 %
Amgen Inc.
AMGN 206.58 (27.10.2021) -1.01 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 14.98 (27.10.2021) -1.45 %
Aurora Cannabis Inc.
ACB 6.84 (27.10.2021) -2.70 %
Becton Dickinson and Company
BDX 245 (27.10.2021) -0.55 %
Biogen Inc.
BIIB 259.95 (27.10.2021) -4.12 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 137.1 (27.10.2021) -3.05 %
BioNTech SE
BNTX 278.77 (27.10.2021) -4.66 %
bluebird bio, Inc.
BLUE 22.06 (27.10.2021) 5.30 %
Boston Scientific Corp.
BSX 43.73 (27.10.2021) -1.33 %
Bristol-Myers Squibb Company
BMY 56.49 (27.10.2021) -3.00 %
Canopy Growth Corp.
CGC 12.78 (27.10.2021) -2.96 %
Castle Biosciences, Inc.
CSTL 60.74 (27.10.2021) -1.41 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 7.91 (15.10.2021) -2.59 %
Eli Lilly and Company
LLY 250.17 (27.10.2021) 0.70 %
Emergent BioSolutions Inc.
EBS 48.23 (27.10.2021) -4.27 %
Exelixis, Inc.
EXEL 21.3 (27.10.2021) -1.66 %
G1 Therapeutics, Inc.
GTHX 13.39 (27.10.2021) -2.41 %
Gilead Sciences, Inc.
GILD 66.77 (27.10.2021) -1.42 %
GlaxoSmithKline plc
GSK 40.42 (27.10.2021) 0.60 %
GoodRx Holdings, Inc.
GDRX 42.42 (27.10.2021) -4.35 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 64.97 (27.10.2021) -2.37 %
Inovio Pharmaceuticals, Inc.
INO 6.79 (27.10.2021) -0.73 %
Johnson & Johnson
JNJ 163.74 (27.10.2021) -1.21 %
Medtronic plc.
MDT 122.5 (27.10.2021) -1.25 %
Merck & Co., Inc.
MRK 81.54 (27.10.2021) -0.86 %
Moderna, Inc.
MRNA 340.88 (27.10.2021) -1.41 %
Novartis AG
NVS 82.73 (27.10.2021) -2.49 %
Novavax, Inc.
NVAX 141.55 (27.10.2021) 4.86 %
ObsEva SA
OBSV 2.58 (27.10.2021) -3.01 %
OrganiGram Holdings Inc.
OGI 2.24 (27.10.2021) -1.32 %
Pfizer Inc.
PFE 42.97 (27.10.2021) -1.35 %
Regeneron Pharmaceuticals, Inc.
REGN 589.6 (27.10.2021) -0.43 %
Sanofi
SNY 49.57 (27.10.2021) -0.78 %
Schrodinger, Inc.
SDGR 53.73 (27.10.2021) -1.90 %
Senseonics Holdings, Inc.
SENS 3.33 (27.10.2021) -2.63 %
Sorrento Therapeutics, Inc.
SRNE 6.69 (27.10.2021) -0.59 %
Stryker Corp.
SYK 268.5 (27.10.2021) -1.71 %
Sundial Growers Inc.
SNDL 0.6525 (27.10.2021) -1.85 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.93 (27.10.2021) -4.90 %
Thermo Fisher Scientific Inc.
TMO 612.29 (27.10.2021) 0.65 %
Tilray, Inc.
TLRY 10.3 (27.10.2021) -3.83 %
UnitedHealth Group, Inc.
UNH 453.48 (27.10.2021) -0.26 %
Veeva Systems Inc.
VEEV 313.46 (27.10.2021) -2.95 %
Zomedica Corp.
ZOM 0.5 (27.10.2021) -2.84 %
Zynerba Pharmaceuticals, Inc.
ZYNE 3.71 (27.10.2021) -1.33 %

Warning: include(include/reklama_bottom.php): failed to open stream: No such file or directory in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808 Warning: include(): Failed opening 'include/reklama_bottom.php' for inclusion (include_path='.:') in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808

Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.